2. Academic Validation
  3. 1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist

1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist

  • J Med Chem. 1995 Nov 10;38(23):4634-6. doi: 10.1021/jm00023a002.
P D Williams 1,  B V Clineschmidt,  J M Erb,  R M Freidinger,  M T Guidotti,  E V Lis,  J M Pawluczyk,  D J Pettibone,  D R Reiss,  D F Veber, et al.
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
PMID: 7473590 DOI: 10.1021/jm00023a002
Figures
Products